To sign up for our newsletter or print publications, please enter your contact information below.
This symptom management article describes the approach to rasburicase-induced hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, which may occur intravascularly in this patient population.
The authors describe a case of an undetectable everolimus level in a patient with kidney cancer who received phenobarbital and was hospitalized because of heart failure.
This single-institution study led by Caroline Townley, PharmD, compares the use of the Onpro device and the manual injection of pegfilgrastim and discusses the potential implications of the findings.
